{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:26:04Z","timestamp":1775183164849,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prisons are considered as major reservoirs for tuberculosis. Preventive therapy for latent TB infection (LTBI) is an adjunctive strategy to control TB. However, LTBI data in Thai prisoners is limited. This study assessed the prevalence of LTBI and feasibility of isoniazid preventive therapy (IPT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted among prisoners in Klong Prem Central Prison, Bangkok. Participants were screened for active TB by questionnaire and chest X-ray. LTBI was evaluated by Tuberculin skin test (TST) and QuantiFERON-TB Gold Plus (QFTP) among subgroup. Participants with positive TST or QFTP were considered to have LTBI. Participants with LTBI were offered IPT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From August 2018\u2013November 2019, 1002 participants were analyzed. All participants were male with a median age of 38 (IQR 32\u201350) years. LTBI identified by either TST\/QFTP was present in 466 (46.5%) participants. TST was positive in 359 (36%) participants. In the subgroup of 294 participants who had both TST and QFTP results, 181\/294 (61.6%) tested positive by QFTP. Agreement between TST and QFTP was 55.1% (Kappa\u2009=\u20090.17). The risk factors associated with LTBI were previous incarceration (aOR 1.53, 95%CI, 1.16\u20132.01, <jats:italic>p<\/jats:italic>\u2009=\u20090.002), history of prior active TB (aOR 3.02, 95%CI, 1.74\u20135.24, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and duration of incarceration \u226510\u2009years (aOR 1.86, 95%CI, 1.24\u20132.79, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). Majority of LTBI participants (82%) agreed to take IPT. Three hundred and 56 (93%) participants completed treatment whereas 27 (7%) participants discontinued IPT due to the side effects of INH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first study to evaluate the prevalence of LTBI and feasibility of IPT among Thai prisoners. LTBI prevalence in male prisoners in Thailand is high. LTBI screening and treatment should be implemented together with other preventive components.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11271-0","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T02:02:38Z","timestamp":1624500158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Sivaporn","family":"Gatechompol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weerakit","family":"Harnpariphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruamthip","family":"Supanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gompol","family":"Suwanpimolkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamon","family":"Kawkitinarong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"11271_CR1","unstructured":"World Health Organization. Global tuberculosis report 1997\u20132020. Geneva; 2020. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data. Accessed 20 Apr 2021"},{"key":"11271_CR2","unstructured":"World Health Organization. Tuberculosis. Key facts. Geneva; 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed 20 Apr 2021"},{"key":"11271_CR3","unstructured":"USAID. Tuberculosis in prisons: a growing public health challenge. USA; 2014. https:\/\/www.usaid.gov\/sites\/default\/files\/documents\/1864\/USAID-TB-Brochure.pdf. Accessed 20 Apr 2021"},{"issue":"suppl_6","key":"11271_CR4","doi-asserted-by":"publisher","first-page":"S644","DOI":"10.1093\/infdis\/jix354","volume":"216","author":"B Mathema","year":"2017","unstructured":"Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, et al. Drivers of tuberculosis transmission. J Infect Dis. 2017;216(suppl_6):S644\u2013S53. https:\/\/doi.org\/10.1093\/infdis\/jix354.","journal-title":"J Infect Dis"},{"issue":"36","key":"11271_CR5","doi-asserted-by":"publisher","first-page":"13280","DOI":"10.1073\/pnas.0801200105","volume":"105","author":"D Stuckler","year":"2008","unstructured":"Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A. 2008;105(36):13280\u20135. https:\/\/doi.org\/10.1073\/pnas.0801200105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11271_CR6","unstructured":"World Health Organization. Tuberculosis in prisons. Geneva; 2013. https:\/\/www.who.int\/tb\/areas-of-work\/population-groups\/prisons\/en\/. Accessed 20 Apr 2021"},{"key":"11271_CR7","unstructured":"World Health Organization. Use of high-burden country lists for TB by WHO in the post-2015 era. Geneva; 2015. https:\/\/www.who.int\/tb\/publications\/global_report\/high_tb_burdencountrylists2016-2020.pdf. Accessed 20 Apr 2021"},{"key":"11271_CR8","unstructured":"World Prison Brief. Highest to Lowest - Prison Population Total. UK; 2020. https:\/\/www.prisonstudies.org\/highest-to-lowest\/prison-population-total?field_region_taxonomy_tid=All. Accessed 20 Apr 2021"},{"key":"11271_CR9","unstructured":"Jittimanee S, Vorasingha J, Poopatana S, Smithikarn S, Kamolwat P. Nationwide chest X-ray screening for active TB in Thai prisons [abstract]. The Hague: The 49th World Conference on Lung Health; 24-27 October 2018; Abstract no: PS 49-934-27"},{"issue":"9979","key":"11271_CR10","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801. https:\/\/doi.org\/10.1016\/S0140-6736(15)60570-0.","journal-title":"Lancet"},{"key":"11271_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tube.2018.10.014","volume":"113","author":"NP Allen","year":"2018","unstructured":"Allen NP, Swarbrick G, Cansler M, Null M, Salim H, Miyamasu M, et al. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB gold-plus TB1 and TB2 tubes. Tuberculosis. 2018;113:239\u201341. https:\/\/doi.org\/10.1016\/j.tube.2018.10.014.","journal-title":"Tuberculosis"},{"key":"11271_CR12","unstructured":"National Library of Thailand Cataloging in Publication Data. National Tuberculosis Control Programme Guideline. Thailand; 2018. https:\/\/www.tbthailand.org\/download\/Manual\/NTP2018.pdf. Accessed 20 Apr 2021"},{"issue":"2","key":"11271_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/resp.12442","volume":"20","author":"T Khawcharoenporn","year":"2015","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Phetsuksiri B, Rudeeaneksin J, Srisungngam S, Mundy LM. Tuberculin skin test and QuantiFERON-TB gold in-tube test for latent tuberculosis in Thai HIV-infected adults. Respirology. 2015;20(2):340\u20137. https:\/\/doi.org\/10.1111\/resp.12442.","journal-title":"Respirology"},{"issue":"3","key":"11271_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7883\/yoken.JJID.2015.181","volume":"69","author":"T Khawcharoenporn","year":"2016","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Sangkitporn S, Rudeeaneksin J, Srisungngam S, Bunchoo S, et al. Tuberculin skin test and QuantiFERON((R))-TB gold in-tube test for diagnosing latent tuberculosis infection among Thai healthcare workers. Jpn J Infect Dis. 2016;69(3):224\u201330. https:\/\/doi.org\/10.7883\/yoken.JJID.2015.181.","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"11271_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3201\/eid2603.190891","volume":"26","author":"G Zhang","year":"2020","unstructured":"Zhang G, Zhang Y, Zhong D, Meng S, An L, Wei W, et al. High prevalence of and risk factors for latent tuberculosis infection among prisoners, Tianjin, China. Emerg Infect Dis. 2020;26(3):516\u201322. https:\/\/doi.org\/10.3201\/eid2603.190891.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"11271_CR16","doi-asserted-by":"publisher","first-page":"e0233314","DOI":"10.1371\/journal.pone.0233314","volume":"15","author":"B Chekesa","year":"2020","unstructured":"Chekesa B, Gumi B, Chanyalew M, Zewude A, Ameni G. Prevalence of latent tuberculosis infection and associated risk factors in prison in east Wollega zone of western Ethiopia. PLoS One. 2020;15(5):e0233314. https:\/\/doi.org\/10.1371\/journal.pone.0233314.","journal-title":"PLoS One"},{"issue":"1","key":"11271_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12879-015-0764-8","volume":"15","author":"S Carbone Ada","year":"2015","unstructured":"Carbone Ada S, Paiao DS, Sgarbi RV, Lemos EF, Cazanti RF, Ota MM, et al. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study. BMC Infect Dis. 2015;15(1):24. https:\/\/doi.org\/10.1186\/s12879-015-0764-8.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"11271_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.5588\/ijtld.15.0857","volume":"20","author":"M Mamani","year":"2016","unstructured":"Mamani M, Mahmudian H, Majzoobi MM, Poorolajal J. Prevalence and incidence rates of latent tuberculous infection in a large prison in Iran. Int J Tuberc Lung Dis. 2016;20(8):1072\u20137. https:\/\/doi.org\/10.5588\/ijtld.15.0857.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"11271_CR19","doi-asserted-by":"publisher","first-page":"e0209895","DOI":"10.1371\/journal.pone.0209895","volume":"14","author":"J Guerra","year":"2019","unstructured":"Guerra J, Mogollon D, Gonzalez D, Sanchez R, Rueda ZV, Parra-Lopez CA, et al. Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Columbia. PLoS One. 2019;14(1):e0209895. https:\/\/doi.org\/10.1371\/journal.pone.0209895.","journal-title":"PLoS One"},{"issue":"1","key":"11271_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2458-14-22","volume":"14","author":"HA Al-Darraji","year":"2014","unstructured":"Al-Darraji HA, Kamarulzaman A, Altice FL. Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health. 2014;14(1):22. https:\/\/doi.org\/10.1186\/1471-2458-14-22.","journal-title":"BMC Public Health"},{"issue":"9","key":"11271_CR21","doi-asserted-by":"publisher","first-page":"e0184986","DOI":"10.1371\/journal.pone.0184986","volume":"12","author":"J Danyuttapolchai","year":"2017","unstructured":"Danyuttapolchai J, Kittimunkong S, Nateniyom S, Painujit S, Klinbuayaem V, Maipanich N, et al. Implementing an isoniazid preventive therapy program for people living with HIV in Thailand. PLoS One. 2017;12(9):e0184986. https:\/\/doi.org\/10.1371\/journal.pone.0184986.","journal-title":"PLoS One"},{"issue":"4","key":"11271_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jiph.2019.08.010","volume":"13","author":"R Miyahara","year":"2020","unstructured":"Miyahara R, Piyaworawong S, Prachamat P, Wongyai J, Bupachat S, Yamada N, et al. High tuberculosis burden among HIV-infected populations in Thailand due to a low-sensitivity tuberculin skin test. J Infect Public Health. 2020;13(4):657\u201360. https:\/\/doi.org\/10.1016\/j.jiph.2019.08.010.","journal-title":"J Infect Public Health"},{"issue":"4","key":"11271_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/QAI.0b013e318258c675","volume":"60","author":"N Phanuphak","year":"2012","unstructured":"Phanuphak N, Varma JK, Kittikraisak W, Teeratakulpisarn N, Phasitlimakul S, Suwanmala P, et al. Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV. J Acquir Immune Defic Syndr. 2012;60(4):384\u201392. https:\/\/doi.org\/10.1097\/QAI.0b013e318258c675.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"11271_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12879-016-1901-8","volume":"16","author":"AE Nijhawan","year":"2016","unstructured":"Nijhawan AE, Iroh PA, Brown LS, Winetsky D, Porsa E. Cost analysis of tuberculin skin test and the QuantiFERON-TB gold in-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA. BMC Infect Dis. 2016;16(1):564. https:\/\/doi.org\/10.1186\/s12879-016-1901-8.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11271_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12879-019-3745-5","volume":"19","author":"S Adams","year":"2019","unstructured":"Adams S, Ehrlich R, Baatjies R, Dendukuri N, Wang Z, Dheda K. Predictors of discordant latent tuberculosis infection test results amongst south African health care workers. BMC Infect Dis. 2019;19(1):131. https:\/\/doi.org\/10.1186\/s12879-019-3745-5.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"11271_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1164\/rccm.201508-1595OC","volume":"193","author":"JS Mathad","year":"2016","unstructured":"Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, et al. Quantitative IFN-gamma and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women. Am J Respir Crit Care Med. 2016;193(12):1421\u20138. https:\/\/doi.org\/10.1164\/rccm.201508-1595OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"11271_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1183\/09031936.00045509","volume":"35","author":"L Leidl","year":"2010","unstructured":"Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, Hirsch C, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J. 2010;35(3):619\u201326. https:\/\/doi.org\/10.1183\/09031936.00045509.","journal-title":"Eur Respir J"},{"issue":"4","key":"11271_CR28","first-page":"417","volume":"12","author":"AM Mandalakas","year":"2008","unstructured":"Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, Marais BJ, et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis. 2008;12(4):417\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11271_CR29","doi-asserted-by":"publisher","unstructured":"Hunter RL. The pathogenesis of tuberculosis-the Koch phenomenon reinstated. Pathogens. 2020;9(10). https:\/\/doi.org\/10.3390\/pathogens9100813.","DOI":"10.3390\/pathogens9100813"},{"issue":"11","key":"11271_CR30","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1086\/644784","volume":"200","author":"JH Elliott","year":"2009","unstructured":"Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis. 2009;200(11):1736\u201345. https:\/\/doi.org\/10.1086\/644784.","journal-title":"J Infect Dis"},{"issue":"1","key":"11271_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):100\u201311. https:\/\/doi.org\/10.1183\/09031936.00114810.","journal-title":"Eur Respir J"},{"issue":"10","key":"11271_CR32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.5588\/ijtld.14.0179","volume":"18","author":"ZV Rueda","year":"2014","unstructured":"Rueda ZV, Arroyave L, Marin D, Lopez L, Keynan Y, Giraldo MR, et al. High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons. Int J Tuberc Lung Dis. 2014;18(10):1166\u201371. https:\/\/doi.org\/10.5588\/ijtld.14.0179.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"11271_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5588\/ijtld.11.0447","volume":"16","author":"HA Al-Darraji","year":"2012","unstructured":"Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in correctional facilities: a systematic review. Int J Tuberc Lung Dis. 2012;16(7):871\u20139. https:\/\/doi.org\/10.5588\/ijtld.11.0447.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11271_CR34","volume-title":"Tuberculosis Control in Prisons: a manual for programme managers","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Tuberculosis Control in Prisons: a manual for programme managers. Geneva: WHO\/CDS\/TB\/2001.281; 2000. https:\/\/www.who.int\/tb\/publications\/prisons_tb_control_manual\/en\/. Accessed 20 Apr 2021"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11271-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11271-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11271-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T02:02:46Z","timestamp":1624500166000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11271-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11271"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11271-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Department of Corrections, Ministry of Justice, Thailand and the ethics committees of Chulalongkorn University. This study was conducted according to Declaration of Helsinki and Good Clinical Practice. All participants provided signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1206"}}